Tetra Bio-Pharma
About Tetra Bio-Pharma
Tetra Bio-Pharma is an Ottawa-based biopharmaceutical company focused on developing cannabinoid-based prescription drug products. The company pursues the drug development pathway to bring cannabis-derived medicines through clinical trials and regulatory approval, bridging the gap between cannabis and traditional pharmaceuticals.
Key Facts
- 1Developing cannabinoid-based prescription drugs through the traditional pharmaceutical approval pathway
- 2Advanced CAUMZ through clinical trials as a cannabis-based pain treatment
- 3Holds a Drug Establishment License from Health Canada
- 4One of the few companies pursuing FDA and Health Canada drug approval for cannabinoid medicines
Frequently Asked Questions
How is Tetra Bio-Pharma different from other cannabis companies?
Unlike most cannabis companies that sell cannabis products, Tetra Bio-Pharma develops cannabinoid-based prescription drugs through traditional pharmaceutical clinical trial and regulatory approval pathways with Health Canada and the FDA.
What is CAUMZ?
CAUMZ is Tetra Bio-Pharma's cannabis-derived drug candidate for pain management that has undergone clinical trials. If approved, it would be a prescription cannabinoid medicine available through pharmacies.
More Cannabis Companies in Ottawa
Products
- ARDS-003 (cannabinoid drug candidate)
- CAUMZ (cannabis pain treatment)
- Cannabinoid-based drug pipeline
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Ottawa, Canada
- Founded
- 2014
- Publicly Traded
- No